Bicycle Therapeutics plc American Depositary Shares (BCYC) is a publicly traded Healthcare sector company. As of July 30, 2026, BCYC trades at $3.89 with a market cap of $275.06M and a P/E ratio of -1.09. BCYC moved +0.75% today. Year to date, BCYC is -45.48%; over the trailing twelve months it is -54.69%. Its 52-week range spans $3.85 to $21.50. Analyst consensus is buy with an average price target of $10.20. Rallies surfaces BCYC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
6 analysts cover BCYC: 0 strong buy, 3 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $10.20.
| Metric | Value |
|---|---|
| Price | $3.89 |
| Market Cap | $275.06M |
| P/E Ratio | -1.09 |
| EPS | $-3.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.50 |
| 52-Week Low | $3.85 |
| Volume | 2.05K |
| Avg Volume | 0 |
| Revenue (TTM) | $28.34M |
| Net Income | $-250.66M |
| Gross Margin | 0.00% |
6 analysts cover BCYC: 0 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.20.